Franklin Resources’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Buy
174,911
+581
+0.3% +$8.9K ﹤0.01% 1746
2026
Q1
$2.42M Sell
174,330
-108,074
-38% -$1.72M ﹤0.01% 1841
2025
Q4
$4.59M Buy
282,404
+116,884
+71% +$1.91M ﹤0.01% 1433
2025
Q3
$2.48M Buy
165,520
+53,218
+47% +$648K ﹤0.01% 1700
2025
Q2
$1.31M Buy
112,302
+17,694
+19% +$161K ﹤0.01% 1877
2025
Q1
$703K Buy
94,608
+20,764
+28% +$160K ﹤0.01% 2122
2024
Q4
$443K Buy
+73,844
New +$407K ﹤0.01% 2342
2024
Q3
Sell
-127,975
Closed -$463K 2919
2024
Q2
$463K Buy
127,975
+26,526
+26% +$84.2K ﹤0.01% 2260
2024
Q1
$326K Buy
101,449
+86,385
+573% +$334K ﹤0.01% 2436
2023
Q4
$73.8K Sell
15,064
-532
-3% -$2.43K ﹤0.01% 2500
2023
Q3
$85K Sell
15,596
-19,896
-56% -$132K ﹤0.01% 2477
2023
Q2
$238K Buy
35,492
+16,390
+86% +$122K ﹤0.01% 2307
2023
Q1
$169K Sell
19,102
-32
-0.2% -$282 ﹤0.01% 2034
2022
Q4
$146K Buy
19,134
+434
+2% +$3.38K ﹤0.01% 2065
2022
Q3
$133K Buy
+18,700
New +$176K ﹤0.01% 2060

Other funds holding ADPT

Franklin Resources's ADPT Position: Q2 2026 in Review

Franklin Resources increased its Adaptive Biotechnologies (ADPT) stake by 0.33% in Q2 2026, buying an estimated $8.9K and bringing the position to 174,911 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1746.

Franklin Resources first reported a position in ADPT in Q3 2022 and has held it in 15 quarters since. The position peaked at $4.59M in Q4 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Franklin Resources held 174,911 shares of Adaptive Biotechnologies worth $3.75M as of Q2 2026.
  • Franklin Resources bought 581 Adaptive Biotechnologies shares in Q2 2026, an estimated $8.9K.
  • Adaptive Biotechnologies made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1746 holding.
  • Franklin Resources first reported a position in Adaptive Biotechnologies in Q3 2022 and has held it in 15 quarters since.
  • Franklin Resources's Adaptive Biotechnologies position peaked at $4.59M in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.